Skip to search formSkip to main contentSkip to account menu

Ipratropium Bromide

Known as: N-Isopropylnoratropinium bromomethylate, Bromure d'ipratropium, (endo,syn)-(±)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide 
The bromide salt form of ipratropium, a synthetic derivative of the alkaloid atropine with anticholinergic properties. Ipratropium antagonizes the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
OBJECTIVE To determine whether the addition of repeated doses of nebulized ipratropium bromide (IB) to a standardized inpatient… 
Review
2001
Review
2001
Ipratropium bromide is a quaternary anticholinergic bronchodilator that is commonly used to treat obstructive lung disease… 
Highly Cited
2000
Highly Cited
2000
We designed a larger, double-blind, randomized, prospective trial to test our hypothesis that patients with acute asthma given… 
Review
1999
Review
1999
Objective. To determine if the addition of ipratropium bromide to the emergency department (ED) treatment of childhood asthma… 
Highly Cited
1993
Highly Cited
1993
To audit the assessment and treatment of acute asthma and the subsequent application of the Australian Asthma Management Plan. 
Highly Cited
1990
Highly Cited
1990
Although the muscarinic antagonist Ipratropium bromide is used clinically as a bronchodilator in infants ventilated because of… 
1989
1989
Inhaled ipratropium bromide (IPR) is effective in the management of COPD. The purpose of this study was to determine if doubling… 
Highly Cited
1984
Highly Cited
1984
In a double blind crossover trial, we compared sodium cromoglycate, ipratropium bromide, and water in 23 asthmatic children less… 
1982
1982
Eighteen children between 6 and 14 years of age with perennial asthma were studied over two four-week treatment periods…